Interestingly, Kim 19 first revealed that SPOCK1‐mediated EMT signalling conferred acquired resistance to lapatinib in human epidermal growth factor receptor 2 (HER2)‐positive gastric cancer. The gene discussed is ERBB2; the disease is gastric cancer.